Long-term study of survival factors in intestinal tuberculosis
Part of Digestive system, Infections clinical trials.
This 15-year study follows patients with intestinal tuberculosis (a bacterial infection of the digestive tract) to understand what factors affect how long patients survive and live with this condition. The research may help doctors better predict outcomes and improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old when diagnosed with intestinal tuberculosis
- Your intestinal tuberculosis diagnosis is confirmed by clinical signs, lab tests, imaging scans, and/or tissue samples
- You either have complete medical records from 2011–2025 (if enrolled in the past-data group) or are newly diagnosed and can attend regular follow-up visits (if newly enrolled)
- You can understand and follow study instructions and agree to participate (no serious cognitive impairment or untreated mental illness)
- You do not have other severe forms of tuberculosis (like brain or bloodstream TB) or life-threatening conditions like advanced cancer or organ failure that would likely cause death during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
This study tracks people with tuberculosis that is mainly outside the lungs (extrapulmonary TB). It collects medical information and samples to better understand the disease and improve care. If you have this type of TB, joining could help advance knowledge and treatment.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
This trial tests whether adding dedicated nursing support in and out of the hospital helps people with tuberculosis complete their treatment and recover better.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study follows people who are newly treated for tuberculosis, including lung and non-lung (extra-lung) cases. It may help doctors better understand tuberculosis and how patients respond after treatment starts.
Hear when a new Intestinal Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.